The engagement of NCRs, primarily NKp30, can also induce the release of the chemotactic form of HMGB1, thus amplifying the antitumor response by attracting additional NK cells at the site of tumor-NK cell interaction [37]. The gene discussed is NCR3; the disease is neoplasm.